The Ontario Pharmacists Association (OPA) welcomes the second report issued today by Premier Ford’s Council on Improving Healthcare and Ending Hallway Medicine and looks forward to being part of the solution to improving the design and delivery of services in Ontario so that patients receive the right care, at the right time and in the right setting.
The report provides 10 policy recommendations and associated actions that focus on four themes: integration, innovation, efficiency and alignment, and capacity – all strategically linked to achieve the objectives of the internationally recognized quadruple aim of healthcare:
- Improving the patient and caregiver experience;
- Improving the health of populations;
- Reducing the per capita cost of healthcare while striving for value for money invested; and,
- Improving the provider experience.
“A number of the recommendations from the report support the government’s commitment in the 2019 budget to expand pharmacists’ scope of practice, including their authority to assess and, when necessary, treat patients for common ailments,” says Jen Baker, Chair of the Board for OPA. “We’re eager to continue working alongside our healthcare partners to ensure patients, whether in the community, long-term care home or hospital, have access to services within a fully integrated, multi-disciplinary healthcare system.”
OPA supports many of the proposed action items of the report and highlights the following three areas that reflect the expanded role of pharmacists in Ontario:
- “Ensure providers are well-supported and maximizing their permitted scope of practice.” (p.36) – OPA is committed to collaborating with the Ontario College of Pharmacists, the Ministry of Health and Ministry of Long-Term Care to ensure that pharmacists are well-equipped to deliver the care their patients need;
- “Work with primary care providers to ensure they have information sharing and referral tools to link with all appropriate community providers, enabling seamless transitions for patients, with continued involvement by primary care.” (p.22) and “Enabling health data to be shared between providers so that patients receive better-integrated care, and so that providers will have a more complete picture of their patients’ health status.” (p.20) – Pharmacists are the most accessible healthcare providers in the community with more than 4,400 pharmacies across Ontario, many of which are open late and even 24/7. The information community pharmacists document in their provision of care for their patients is invaluable to other healthcare professionals. Pharmacy management systems are beginning to get integrated with physician-based electronic medical records via clinical viewers to enable multi-directional and multi-disciplinary sharing of information so that patients can take comfort in knowing that providers within their circle of care are communicating with each other. Ontario’s pharmacists fully support making patient data accessible so that healthcare providers have a more fulsome picture of a patient’s health and can ensure the most appropriate care is provided; and
- “Support health sector leaders and ensure they have the skills and tools to lead by example and support the sector through a fundamental culture change.” (p.38) – OPA provides members of the pharmacy community with professional development to ensure the pharmacy community is prepared for healthcare transformation, including accredited programs relating to cannabis, immunization and injections and treating common ailments.
“The changes we are seeing in healthcare right now are more than just a transformation in structure. These action items will put patients at the centre of their care and will ensure they are supported inter-professionally by healthcare professionals within their circle of care, which includes their pharmacist,” says Baker. “More than ever, Ontario’spharmacists are ready and want to provide more care. Patients and government need to rethink pharmacy and recognize the level of service and expertise pharmacists are trained to provide to help keep Ontarians healthy.”
Pharmacists continue to demonstrate their integral role across the healthcare continuum. Just this year, pharmacists administered more than 1.2 million flu vaccines to patients across Ontario. In addition, pharmacists are helping to protect communities by providing vaccines for 13 diseases including hepatitis A and B, HPV, varicella (chicken pox), meningococcal disease and pneumococcal disease.
“Pharmacists are trained healthcare professionals who can help. Not only can we keep patients out of emergency departments, but we can keep patients and their whole communities protected and healthy,” says Bill Wilson, OPA’s interim CEO. “Ontario pharmacists are ready to contribute to the Ford government’s new vision of a long-term, modern, sustainable, efficient and integrated healthcare system focused on the patient.”
SOURCE Ontario Pharmacists Association
Digipath CEO Todd Denkin Interviewed by CEO Roadshow
Digipath, Inc. (OTCQB: DIGP) (“DIGP” or the “Company”), a service-oriented independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that Company CEO Todd Denkin was recently interviewed by CEO Roadshow with veteran journalist Mike Elliott.
In this interview, Denkin discusses the Company’s recent provisional patent applications involving terpene technology. He also discusses Digipath’s newest business unit, GroSciences and the molecular assay it has developed to distinguish hemp from drug-type cannabis, and the status of the Company’s expansion into Colombia.
“It’s always a pleasure to sit down with Mr. Elliott, who is a true professional with a significant following,” stated Todd Denkin, CEO, Digipath Inc. “In this interview we covered some of the more exciting things happening for Digipath and its shareholders. “Please take a moment to listen to the interview at http://ceoroadshow.com/digipath-interview/,” added Denkin.
SOURCE Digipath, Inc.
Vireo Health Launches New York’s First Same-Day Marijuana Delivery Service
Vireo Health of New York (“Vireo” or the “Company”), a subsidiary of Vireo Health International (CSE: VREO), a leading physician-led, science-focused multi-state cannabis company, today announced that patients living in the New York City metro area, Westchester County, and Nassau County now have access to free, same-day marijuana delivery.
Launched in April 2017, Vireo’s medical marijuana home delivery service has rapidly expanded. Since its inception, the Company has made more than 25,000 home deliveries to patients. With over 1,000 Google reviews with an average 4.9 out of 5 star rating, it is now the first company in New York to offer a free same-day delivery option.
“Our same-day home delivery service is designed to match the convenience that New Yorkers have become accustomed to in the era of Amazon, Uber and Seamless,” said Founder and Chief Executive Officer, Kyle Kingsley, M.D. “The growing popularity of our home delivery service has allowed us to achieve the economies of scale necessary to offer same-day delivery throughout the Greater New York City area.”
Vireo’s home delivery service was designed by a team of security experts, pharmacists, and health-care providers. “As a physician-led company, our goal is to provide safe and effective products in a trusted and supportive environment, and nothing is safer than one’s own home. We want to ensure that all our patients do not feel stigmatized and can receive the highest quality service and products with the convenience they deserve,” said Stephen Dahmer, M.D., Chief Medical Officer of Vireo Health.
Patients who place orders by 12:00 p.m. EDT will be eligible to receive free same-day delivery. Payment for deliveries can be made using CanPay, a cannabis debit payment app available on iPhone and Android devices. More information is available online at www.vireohealth.com/ny/delivery.
SOURCE Vireo Health International, Inc.
Choom Announces Warrant Extension
Vancouver-based cannabis brand Choom (CSE: CHOO; OTCQB: CHOOF) has amended the expiry date of 2,352,500 outstanding share purchase warrants that were issued pursuant to a private placement completed in February 2018 (the “2018 Warrants”). Each 2018 Warrant currently entitles the holder to purchase one common share (a “Common Share”) in the capital of the Company at a price of $0.75 per Common Share at any time prior to 5:00 p.m. (Vancouver Time) on August 6, 2019 (the “2018 Warrant Expiry Date”). Subject to Canadian Securities Exchange approval, the 2018 Warrant Expiry Date will be extended to August 6, 2020. All other terms of the 2018 Warrants will remain the same.
Say hello to Choom
Choom is an emerging adult use cannabis company whose mission is to establish one of the largest retail networks in Canada. The Choom brand is inspired by Hawaii’s “Choom Gang”—a group of buddies in Honolulu during the 1970’s who loved to smoke weed—or as the locals called it, “Choom”. Evoking the spirit of the original Choom Gang, our brand caters to the Canadian adult use market with the ethos of ‘cultivating good times’. Choom is focused on delivering an elevated customer experience through our curated retail environments, offering a diversity of brands for Canadians across a national retail network.
President & CEO
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release contains forward-looking information relating to the Company’s proposed activities and other statements that are not historical facts. Forward-looking information relates to management’s future outlook and anticipated events or results and include statements or information regarding the future plans or prospects of the Company. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. These factors include risks and uncertainties associated with or arising as a result of delays in obtaining or an inability to obtain required regulatory approvals, access to sufficient quantities of cannabis, the results of diligence investigations, the actions of third parties, the results of negotiations with third parties, developments in the cannabis sector, the ability to access sufficient capital from internal and external sources, reliance on key personnel, regulatory risks and delays and other risks and uncertainties discussed in the management discussion and analysis section of the Company’s interim and most recent annual financial statement or other reports and filings, including those made with the CSE and applicable Canadian securities regulators. There can be no assurance that such forward looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking information.
SOURCE Choom Holdings Inc.
Cannabis3 weeks ago
Ignite Breaks into Topicals, Announces CBD Pain Relief Cream and Roll-On
Cannabis3 weeks ago
Fire & Flower Completes Bought Deal Financing
Cannabis3 weeks ago
Cannabis Cultivation and Extraction Potentially Costs 80% Less in Latin America
Cannabis4 weeks ago
Rights 4 Vapers Reaction to Study Showing Increase in Vaping Among Youth in Canada
Cannabis1 week ago
California Based Lifestyle & Cannabis Brand, Cookies, To Launch Exclusive “Gary Payton” Strain Named After Hall Of Fame Basketball Player
Cannabis3 weeks ago
ONE Cannabis Stacks Leadership Team, Adding Chief Financial Officer, Director of Operations and Director of Communications
Cannabis1 week ago
Vapen CBD Announces Exclusive THC-Free CBD Inhaler
Cannabis1 week ago
The Best CBD for Pain Ranked by Best CBD Oils